Three innovative Irish healthcare start-ups have advanced to the next round of the prestigious EIT Health Catapult 2024-25 pitching competition.
EIT Health Ireland-UK, a co-location centre of EIT Health and part of the EU’s European Institute of Innovation and Technology (EIT), has announced that Galenband, Tympany Medical, and ArrayPatch have all been selected for the semi-finals.
Galenband has developed a wearable device that provides 90-day continuous ECG monitoring for reliable, non-invasive diagnosis for intermittent heart rhythm issues.
Tympany Medical’s Solascope technology is the world’s first variable angle and self-cleaning imaging tool, creating a more sustainable and advanced approach to surgical visualisation.
ArrayPatch, a BioTech spin-out, leverages its patented microneedle technology, DerMap, to create therapeutics that are more effective and user-friendly, beginning with solutions for nail fungal infections.
The companies are three of 30 semi-finalists in this year’s EIT Health Catapult, each of which has passed a rigorous pre-selection process and will receive tailored mentoring …